
- Backed Unimed Acquires MedSupply Florida, Expanding Cruise Industry Market Share
UNEW YORK--(BUSINESS WIRE)--Universal Marine Medical Supply International (“Unimed” or the “Company”), the leading global provider of pharmaceutical and medical solutions to the maritime industry and a ZCG portfolio company, today announced the successful acquisition of MedSupply International FL, LLC (“MedSupply Florida”), a subsidiary of International SOS and a prominent supplier of medical provisions to the global cruise industry. Financial terms of the transaction were not disclosed.
Similar to Unimed, MedSupply Florida specializes in providing pharmaceuticals, medical equipment, and essential medical supplies. The strategic location of MedSupply Florida’s facilities at the Fort Lauderdale and Miami cruise ports aligns with Unimed’s long-term expansion objectives. Through this acquisition, Unimed is poised to enhance its services to cruise clients in the South Florida region.
“We are pleased to expand our presence in the booming cruise market while continuing to offer exceptional value and industry-leading essential, high-quality medical products and services,” said Alan Kessman, CEO of Unimed. “South Florida is a key port region for Unimed, and we are confident that our existing presence, strengthened by the acquisition of MedSupply Florida, will help us further enhance our longstanding customer relationships. Building on our recent merger with Marine Pharma in Singapore, this transaction represents another significant step in our value-creation strategy under ZCG ownership, positioning Unimed for continued organic growth and acquisition-driven expansion.”
“We are confident in the continued growth opportunities for Unimed to provide pharmaceutical and medical solutions, and meet the evolving demands of the maritime industry,” said James Zenni, Founder, President and Chief Executive Officer of ZCG. “This further expansion into global cruising aligns well with Unimed’s strategy, and we look forward to partnering with leadership and Unimed’s talented employees in this next phase of growth.”